Company: IXHL
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001213900-25-092837
Chunk: 573

Company: Incannex Healthcare Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 2
Chunk 573
---
 will be fully completed, and we cannot provide any assurance that these remediation efforts will be successful or
that our internal control over financial reporting will be effective as a result of these efforts.

Attestation Report of the Registered
Public Accounting Firm

This Annual Report does
not include an attestation report of our independent registered public accounting firm due to our status as an emerging growth company
under the JOBS Act.

Changes in Internal Control over Financial Reporting

Other than the remediation of the material weakness
discussed above, there were no changes in our internal controls over financial reporting (as such term is defined in Rules 13a-15(d) and
15d-15(d) under the Exchange Act) that occurred during three months ended June 30, 2025 that have materially affected, or are reasonably
likely to materially affect, our internal control over financial reporting.

Item 9B. Other Information

During the three months ended June 30, 2025, none
of our directors or officers adopted or terminated “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,”
as each term is defined in Item 408 of Regulation S-K.

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent
Inspections

Not applicable.

93

PART III

Item 10. Directors, Executive Officers and Corporate Governance

The information required by this item is incorporated
herein by reference to our Proxy Statement with respect to our 2025 Annual Meeting of Stockholders to be filed with the SEC within 120
days of the end of the fiscal year covered by this Annual Report (“2025 Proxy Statement”).

Item 11. Executive and Director Compensation

The information required by this item is incorporated
herein by reference to our 2025 Proxy Statement.

Item 12. Security Ownership of Certain Beneficial Owners and Management
and Related Stockholder Matters

The information required by this item is incorporated
herein by reference to our 2025 Proxy Statement.

Item 13. Certain Relationships and Related Transactions, and Director
Independence

The information required by this item is incorporated
herein by reference to our 2025 Proxy Statement.

Item 14. Principal Accountant Fees and Services

The information required by this item is incorporated
herein by reference to our 2025 Proxy Statement.

94

PART IV

Item 15. Exhibits and Financial Statement Schedules

(a)(1)

The information
required by